Tag: chronic conditions

The selection of Martin Reincke, MD, as the recipient of the 2026 Outstanding Scholarly Physician Award marks a significant milestone for the international endocrinology community, highlighting a career defined by the seamless integration of high-level academic research and compassionate clinical practice. As a professor of endocrinology and the former chair of Medical Department IV at…

The Endocrine Society and Keystone Symposia have announced a landmark collaborative partnership to launch a multi-year series of scientific meetings designed to investigate the complex intersections between hormone signaling, oncology, diabetes, and cardiometabolic health. This strategic alliance represents a significant shift in the approach to biomedical research, seeking to dissolve the traditional silos that have…

A growing body of scientific evidence has identified a significant link between common environmental chemicals and adverse maternal health outcomes, specifically regarding the development of hypertension during pregnancy. According to a comprehensive study published in the Journal of the Endocrine Society, phthalates—a class of synthetic chemicals found in a vast array of consumer products ranging…

Recent clinical evidence presented at the ENDO 2026 annual meeting suggests that glucagon-like peptide-1 (GLP-1) receptor agonists may provide a dual benefit for men, addressing both metabolic dysfunction and reproductive health. The study, led by Pratibha Natesh, MBBS, MRCP, MRes, an endocrinologist at Warwick Medical School and University Hospitals Coventry and Warwickshire, indicates that these…

The landscape of metabolic surgery is facing a significant and under-addressed clinical challenge as new data suggests a substantial portion of weight-loss surgery patients are suffering from a debilitating condition known as post-bariatric hypoglycemia (PBH). According to a comprehensive multi-study analysis presented at the ENDO 2026 conference, at least one in 12 patients who undergo…

The annual meeting of the Endocrine Society, known as ENDO, remains the premier global gathering for professionals dedicated to the study of hormones and clinical endocrine practice. In June 2026, Chicago served as the backdrop for this high-stakes exchange of medical knowledge, where the Rising Star Power Talks once again emerged as a highlight of…

The medical community is facing a growing challenge in the management of male hypogonadism, as new research presented at the ENDO 2024 conference suggests that a vast majority of men receiving testosterone replacement therapy (TRT) are doing so without undergoing the full battery of diagnostic tests recommended by clinical guidelines. The study, led by Sophia…

The field of endocrinology is currently undergoing a significant transformation driven by a new generation of laboratory technologies designed to meet the increasing demand for precision, speed, and reproducibility. In an era where the study of hormonal systems is becoming increasingly complex—covering everything from metabolic disorders and reproductive health to the long-term impacts of endocrine…

Ascendis Pharma A/S, a biopharmaceutical leader headquartered in Copenhagen, Denmark, announced on August 6 a series of pivotal updates regarding its clinical pipeline for achondroplasia and the commercial performance of its flagship growth hormone therapy in the U.S. market. The most significant revelation involved the Week 78 results from the Phase 2 COACH trial, which…

The global medical community has long recognized that the bridge between laboratory discovery and bedside application is paved by the dedication of scholarly physicians. In recognition of a career defined by this duality, the Endocrine Society has named Martin Reincke, MD, as the recipient of the 2026 Outstanding Scholarly Physician Laureate Award. This honor, among…